Increased prevalence of influenza B/Victoria lineage viruses during early stages of the 2015 influenza season in New South Wales, Australia: implications for vaccination and planning

被引：5
作者：
Jennings, Z. [1 ]
Carter, I. [1 ]
McPhie, K. [1 ]
Kok, J. [1 ,2 ,3 ]
Dwyer, D. E. [1 ,2 ,3 ]
机构：
[1] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Inst Clin Pathol & Med Res, Pathol West, Westmead, NSW 2145, Australia
[2] Univ Sydney, Westmead Hosp, Marie Bashir Inst Infect Dis & Biosecur, Westmead, NSW 2145, Australia
[3] Univ Sydney, Westmead Hosp, Ctr Res Excellence Crit Infect, Westmead, NSW 2145, Australia
来源：
EUROSURVEILLANCE | 2015年 / 20卷 / 31期
关键词：
RANDOMIZED-TRIAL; UNITED-STATES; PROTECTION; CANDIDATE; VACCINES;
D O I：
10.2807/1560-7917.ES2015.20.31.21201
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
During the early weeks of the 2015 Australian influenza season, influenza B accounted for 67% (821/1,234) of all positive influenza tests in New South Wales. Of 81 successive influenza B viruses characterised, 33 (41%) were from children aged <16 years; 23/81 (28%) belonged to the B/Victoria lineage. This lineage is not contained in the southern hemisphere's 2015 trivalent influenza vaccine. The significant B/Victoria lineage activity in the southern hemisphere suggests that the quadrivalent vaccine should be considered for the northern hemisphere.
引用
收藏
页码：2 / 4
页数：3
相关论文
共 20 条
  • [1] The rationale for quadrivalent influenza vaccines
    Ambrose, Christopher S.
    Levin, Myron J.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (01) : 81 - 88
  • [2] Appiah GD, 2015, MMWR-MORBID MORTAL W, V64, P583
  • [3] Prevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands
    Bodewes, R.
    De Mutsert, G.
    van der Klis, F. R. M.
    Ventresca, M.
    Wilks, S.
    Smith, D. J.
    Koopmans, M.
    Fouchier, R. A. M.
    Osterhaus, A. D. M. E.
    Rimmelzwaan, G. F.
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (03) : 469 - 476
  • [4] A Randomized Trial of Candidate Inactivated Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccines in Children Aged 3-17 Years
    Domachowske, Joseph B.
    Pankow-Culot, Heidemarie
    Bautista, Milagros
    Feng, Yang
    Claeys, Carine
    Peeters, Mathieu
    Innis, Bruce L.
    Jain, Varsha
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (12) : 1878 - 1887
  • [5] European Centre for Disease Prevention and Control, 2015, INFL VIR CHAR SUMM E
  • [6] Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility
    Farrukee, Rubaiyea
    Leang, Sook-Kwan
    Butler, Jeff
    Lee, Raphael T. C.
    Maurer-Stroh, Sebastian
    Tilmanis, Danielle
    Sullivan, Sheena
    Mosse, Jennifer
    Barr, Ian G.
    Hurt, Aeron C.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (07) : 2004 - 2012
  • [7] Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1
  • [8] Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years
    Kieninger, Dorothee
    Sheldon, Eric
    Lin, Wen-Yuan
    Yu, Chong-Jen
    Bayas, Jose M.
    Gabor, Julian J.
    Esen, Meral
    Fernandez Roure, Jose Luis
    Narejos Perez, Silvia
    Sanchez, Carmen Alvarez
    Feng, Yang
    Claeys, Carine
    Peeters, Mathieu
    Innis, Bruce L.
    Jain, Varsha
    [J]. BMC INFECTIOUS DISEASES, 2013, 13
  • [9] Clinical and genetic characterization of severe influenza B-associated diseases during an outbreak in Taiwan
    Li, Wen-Chen
    Shih, Shin-Ru
    Huang, Yhu-Chering
    Chen, Guang-Wu
    Chang, Shih-Cheng
    Hsiao, Mei-Jen
    Tsao, Kuo-Chien
    Lin, Tzou-Yien
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2008, 42 (01) : 45 - 51
  • [10] Influenza Vaccine Effectiveness in the United States During 2012-2013: Variable Protection by Age and Virus Type
    McLean, Huong Q.
    Thompson, Mark G.
    Sundaram, Maria E.
    Kieke, Burney A.
    Gaglani, Manjusha
    Murthy, Kempapura
    Piedra, Pedro A.
    Zimmerman, Richard K.
    Nowalk, Mary Patricia
    Raviotta, Jonathan M.
    Jackson, Michael L.
    Jackson, Lisa
    Ohmit, Suzanne E.
    Petrie, Joshua G.
    Monto, Arnold S.
    Meece, Jennifer K.
    Thaker, Swathi N.
    Clippard, Jessie R.
    Spencer, Sarah M.
    Fry, Alicia M.
    Belongia, Edward A.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (10) : 1529 - 1540
12